Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREASURE: Thoracic Radiotherapy with Atezolizumab in ED-SCLC
NCT04462276Phase 2Completed
- Sponsor
- Institut für Klinische Krebsforschung
- Start
- Jul 2020
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of atezolizumab in small cell lung cancer (SCLC), sponsored by Institut für Klinische Krebsforschung. Started Jul 2020; status: completed.
02
Drugs
atezolizumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04462276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462276.